Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype

https://doi.org/10.1046/j.1523-1747.1998.00073.xGet rights and content
Under an Elsevier user license
open archive

Scleroderma fibroblasts exhibit numerous phenotypic differences when compared with healthy skin fibroblasts. Some of these differences, in particular overexpression of collagen type I and other extracellular matrix proteins, parallel the effect of transforming growth factor-β (TGF-β) on dermal fibroblasts, suggesting that the scleroderma fibroblast phenotype may result from activation of autocrine TGF-β signaling. To test this hypothesis we examined the role of TGF-β Type I and Type II receptors in regulating collagen type I transcription. We have shown that overexpression of either Type I or Type II receptors significantly (3–4-fold) increases α2 (I) collagen promoter activity in transient transfection assays in dermal fibroblasts. Addition of anti-TGF-β antibody abolished, whereas addition of plasmin enhanced, the stimulatory effect of receptor overexpression on collagen promoter activity, suggesting that this effect depends on autocrine TGF-β. Moreover, these cotransfection experiments indicated that expression levels of TGF-β receptors is a limiting factor in the autocrine regulation of collagen type I transcription by TGF-β. Comparison of the TGF-β receptor Type I and Type II mRA expression levels in scleroderma and normal fibroblasts have indicated elevated expression (2-fold) of both receptor types in scleroderma cells, which correlated with increased binding of TGF-β. Significantly, elevated TGF-β receptor levels correlated with elevated α2 (I) collagen mRNA levels. These results suggest that the elevated production of collagen type I by scleroderma fibroblasts results from overexpression of TGF-β receptors.

Key words

collagen type I
fibrosis

Cited by (0)